Zdorovʹe Rebenka (May 2019)

Safe use of Cogivis and Silenta neuroadaptogens in pediatric practice

  • M.V. Khaitovych

DOI
https://doi.org/10.22141/2224-0551.14.3.2019.168770
Journal volume & issue
Vol. 14, no. 3
pp. 177 – 181

Abstract

Read online

Over the last decade, the prevalence of autonomic dysfunction in children has significantly increased. Anxiety, insomnia violate the vegetative regulation, cause frequent headaches, blood pressure variability, deterioration of attention, memory, reduce the quality of life of the child and family. We have evaluated the data of evidence-based medicine in the aspect of safe usage of GABA receptor agonists (benzodiazepines, Z-drugs), melatonin and drugs used to treat children with attention deficit hyperactivity disorder (stimulating and non-stimulating), etc. The application of these drugs is often accompanied by side effects, which make it impossible to use them routinely. The alternative is to use combination drugs with synergistic action that minimizes the side effects. The expediency of using Cogivis and Silenta combination drugs for neuroadaptation of children was substantiated.

Keywords